Diana Brainard
Director, Kalaris Therapeutics, Inc.
Companies
- Nektar TherapeuticsBoard member Nov 15, 2021 to now1
- Kalaris Therapeutics, Inc.Chief executive officer May 18, 2021 to Nov 20, 20242
- Kalaris Therapeutics, Inc.Board member Jul 29, 2020 to Nov 20, 20243
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Kalaris Therapeutics, Inc. KLRS723,363 shares4$1.6M at $2.19Nov 19, 2024
- Nektar Therapeutics NKTR3,904 shares5$147.3K at $37.72Sep 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 23, 2026Granted 2,000 shares of Nektar Therapeutics5
- Nov 19, 2024Sold 8,706 shares at $0.55 of Kalaris Therapeutics, Inc.4
- Nov 5, 2024Sold 10,609 shares at $0.86 of Kalaris Therapeutics, Inc.6
- Oct 21, 2024Sold 9,752 shares at $0.78 of Kalaris Therapeutics, Inc.7
- Oct 3, 2024Sold 1,493 shares at $0.81 of Kalaris Therapeutics, Inc.8
- Aug 20, 2024Sold 5,390 shares at $0.74 of Kalaris Therapeutics, Inc.9
- Aug 19, 2024Sold 3,091 shares at $0.76 of Kalaris Therapeutics, Inc.10
- Aug 5, 2024Sold 10,847 shares at $0.73 of Kalaris Therapeutics, Inc.11
- Jul 19, 2024Sold 9,731 shares at $0.75 of Kalaris Therapeutics, Inc.12
- Jul 2, 2024Sold 1,489 shares at $0.72 of Kalaris Therapeutics, Inc.13
- May 21, 2024Sold 5,149 shares at $0.79 of Kalaris Therapeutics, Inc.14
- May 17, 2024Sold 3,075 shares at $0.75 of Kalaris Therapeutics, Inc.15
- May 3, 2024Sold 10,240 shares at $0.80 of Kalaris Therapeutics, Inc.16
- Apr 19, 2024Sold 9,601 shares at $0.75 of Kalaris Therapeutics, Inc.17
- Apr 2, 2024Sold 1,533 shares at $0.77 of Kalaris Therapeutics, Inc.18
- Feb 21, 2024Sold 5,155 shares at $0.71 of Kalaris Therapeutics, Inc.19
- Feb 20, 2024Sold 3,097 shares at $0.70 of Kalaris Therapeutics, Inc.19
- Feb 5, 2024Sold 41,421 shares at $0.67 of Kalaris Therapeutics, Inc.20
- Jan 23, 2024Sold 9,500 shares at $0.67 of Kalaris Therapeutics, Inc.21
- Jan 4, 2024Sold 1,664 shares at $0.64 of Kalaris Therapeutics, Inc.22
- Nov 20, 2023Sold 4,382 shares at $1.69 of Kalaris Therapeutics, Inc.23
- Nov 17, 2023Sold 2,689 shares at $1.63 of Kalaris Therapeutics, Inc.23
- Oct 19, 2023Sold 8,581 shares at $1.58 of Kalaris Therapeutics, Inc.24
- Oct 3, 2023Sold 1,325 shares at $1.98 of Kalaris Therapeutics, Inc.25
- Aug 18, 2023Sold 4,055 shares at $2.79 of Kalaris Therapeutics, Inc.26
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNektar Therapeutics, Board member
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Nov 6, 2024
- 7SEC EDGARForm 4 filed Oct 23, 2024
- 8SEC EDGARForm 4 filed Oct 4, 2024
- 9SEC EDGARForm 4 filed Aug 22, 2024
- 10SEC EDGARForm 4 filed Aug 20, 2024
- 11SEC EDGARForm 4 filed Aug 7, 2024
- 12SEC EDGARForm 4 filed Jul 23, 2024
- 13SEC EDGARForm 4 filed Jul 3, 2024
- 14SEC EDGARForm 4 filed May 23, 2024
- 15SEC EDGARForm 4 filed May 21, 2024
- 16SEC EDGARForm 4 filed May 7, 2024
- 17SEC EDGARForm 4 filed Apr 23, 2024
- 18SEC EDGARForm 4 filed Apr 4, 2024
- 19SEC EDGARForm 4 filed Feb 22, 2024
- 20SEC EDGARForm 4 filed Feb 6, 2024
- 21SEC EDGARForm 4 filed Jan 25, 2024
- 22SEC EDGARForm 4 filed Jan 8, 2024
- 23SEC EDGARForm 4 filed Nov 21, 2023
- 24SEC EDGARForm 4 filed Oct 23, 2023
- 25SEC EDGARForm 4 filed Oct 5, 2023
- 26SEC EDGARForm 4 filed Aug 21, 2023